NovImmune
Plan-les-ouates · Founded 1998
About NovImmune
NovImmmune is committed to innovation by discovering and developing therapeutic monoclonal antibodies (mAbs) to treat patients suffering from immune-related disorders.
Company Facts
- Founded: 1998
- Legal name: Novimmune SA
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $239.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2016)
- Website: lightchainbio.com
- Phone: +41 22 552 72 00
Social Profiles
Canonical: https://fsome.com/organization/novimmune-8372772 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.